Andrew Hsu

2.9k total citations
61 papers, 2.2k citations indexed

About

Andrew Hsu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Andrew Hsu has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Andrew Hsu's work include Gastric Cancer Management and Outcomes (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Andrew Hsu is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Andrew Hsu collaborates with scholars based in United States, France and Syria. Andrew Hsu's co-authors include Xiaohong Chen, Kai Chen, Lewis Hou, Shouheng Sun, Jin Xie, Ha‐Young Lee, Chenjie Xu, Anand Veeravagu, Zibo Li and Victor C. K. Tse and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew Hsu

58 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Hsu United States 18 592 583 533 328 325 61 2.2k
Jörg Bornemann Germany 17 716 1.2× 547 0.9× 523 1.0× 93 0.3× 600 1.8× 20 2.5k
Hao Fu China 31 794 1.3× 1.0k 1.8× 375 0.7× 239 0.7× 476 1.5× 164 3.3k
Josef Ehling Germany 24 1.2k 2.0× 631 1.1× 802 1.5× 386 1.2× 392 1.2× 37 2.7k
Chunchao Xia China 26 608 1.0× 343 0.6× 563 1.1× 684 2.1× 436 1.3× 120 2.4k
Jianhua Wang China 22 722 1.2× 682 1.2× 214 0.4× 271 0.8× 471 1.4× 106 2.9k
Xiaomin He China 24 462 0.8× 1.5k 2.5× 592 1.1× 556 1.7× 272 0.8× 96 2.9k
Dengfeng Cheng China 24 576 1.0× 740 1.3× 410 0.8× 541 1.6× 226 0.7× 125 2.1k
Olga Şoriţău Romania 25 594 1.0× 542 0.9× 390 0.7× 77 0.2× 287 0.9× 108 1.9k
Simmyung Yook South Korea 27 749 1.3× 517 0.9× 599 1.1× 228 0.7× 144 0.4× 78 1.9k
Haiyan Sun China 26 722 1.2× 561 1.0× 235 0.4× 257 0.8× 307 0.9× 81 2.1k

Countries citing papers authored by Andrew Hsu

Since Specialization
Citations

This map shows the geographic impact of Andrew Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hsu more than expected).

Fields of papers citing papers by Andrew Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hsu. The network helps show where Andrew Hsu may publish in the future.

Co-authorship network of co-authors of Andrew Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hsu. A scholar is included among the top collaborators of Andrew Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hsu. Andrew Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reagan, John L., et al.. (2022). Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.. PubMed. 105(6). 36–40. 2 indexed citations
2.
Hsu, Andrew, Kelsey E. Huntington, André De Souza, et al.. (2022). Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma. Cancer Biology & Therapy. 23(1). 417–423. 12 indexed citations
3.
Hsu, Andrew & Alexander G. Raufi. (2021). Advances in Systemic Therapy for Gastric Cancer. Gastrointestinal Endoscopy Clinics of North America. 31(3). 607–623. 11 indexed citations
4.
Hsu, Andrew, Habibe Kurt, Adam Zayac, & Adam J. Olszewski. (2021). CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. Leukemia & lymphoma. 63(1). 31–42. 7 indexed citations
5.
Hsu, Andrew, et al.. (2020). Stewart–Treves syndrome: a rapidly fatal complication of breast cancer treatment. The Lancet Oncology. 21(10). e495–e495. 2 indexed citations
6.
Hsu, Andrew, et al.. (2020). Targeted therapies for gastroesophageal cancers. Annals of Translational Medicine. 8(17). 1104–1104. 11 indexed citations
7.
Hsu, Andrew, Adam Zayac, Habibe Kurt, & Adam J. Olszewski. (2020). CD5 Expression in Marginal Zone Lymphoma (MZL) Predicts Worse Outcomes with Rituximab (R) but Not with Bendamustine/Rituximab (BR). Blood. 136(Supplement 1). 50–51. 1 indexed citations
8.
Hsu, Andrew, et al.. (2020). Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020. Annals of Translational Medicine. 8(17). 1109–1109. 8 indexed citations
9.
Li, Yue, Tongrong Zhou, Andrew Hsu, et al.. (2019). Metformin reduces inflammation in diabetic human vitreous by activating AMPK and inhibiting NFκB signaling pathway. Investigative Ophthalmology & Visual Science. 60(9). 6548–6548. 2 indexed citations
10.
Hsu, Emily, et al.. (2018). A Case of Granulocytic Sarcoma or Extramedullary Acute Myelomonocytic Leukemia of the Gallbladder. American Journal of Case Reports. 19. 1262–1266. 6 indexed citations
11.
Hsu, Andrew, et al.. (2016). Hypercalcemia due to Primary Hepatic Lymphoma. SHILAP Revista de lepidopterología. 2016. 1–4. 2 indexed citations
12.
Wang, Wei, Victor F. Lundin, Iván Millán, et al.. (2012). Nemitin, a Novel Map8/Map1s Interacting Protein with Wd40 Repeats. PLoS ONE. 7(4). e33094–e33094. 10 indexed citations
13.
Hsu, Andrew, Lewis Hou, Anand Veeravagu, Patrick D. Barnes, & Stephen L. Huhn. (2009). Resolution of syringomyelia after release of tethered cord. Surgical Neurology. 72(6). 657–661. 12 indexed citations
14.
Xie, Jin, Kai Chen, Ha‐Young Lee, et al.. (2008). Ultrasmall c(RGDyK)-Coated Fe 3 O 4 Nanoparticles and Their Specific Targeting to Integrin α v β 3 -Rich Tumor Cells. Journal of the American Chemical Society. 130(24). 7542–7543. 361 indexed citations
15.
Hsu, Andrew, et al.. (2008). Dynamic skeletal traction spica casts for paediatric femoral fractures in a resource-limited setting. International Orthopaedics. 33(3). 765–771. 7 indexed citations
16.
Veeravagu, Anand, Andrew Hsu, Weibo Cai, et al.. (2007). Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy. Recent Patents on Anti-Cancer Drug Discovery. 2(1). 59–71. 56 indexed citations
17.
Hsu, Andrew, Lewis Hou, Anand Veeravagu, et al.. (2006). In Vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in an Orthotopic Glioblastoma Model. Molecular Imaging and Biology. 8(6). 315–323. 70 indexed citations
18.
Hsu, Andrew, et al.. (2006). Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. Journal of Applied Physiology. 100(6). 2031–2040. 105 indexed citations
19.
Hou, Lewis, Anand Veeravagu, Andrew Hsu, & Victor C. K. Tse. (2006). Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurgical FOCUS. 20(4). E3–E3. 227 indexed citations
20.
Leong, Stanley P. L., et al.. (2005). P-315 Epidemiology of lung cancer in Singapore. Lung Cancer. 49. S198–S198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Bornemann Breakdown of academic impact, for papers by Hao Fu Breakdown of academic impact, for papers by Josef Ehling Breakdown of academic impact, for papers by Chunchao Xia Breakdown of academic impact, for papers by Jianhua Wang Breakdown of academic impact, for papers by Xiaomin He Breakdown of academic impact, for papers by Dengfeng Cheng Breakdown of academic impact, for papers by Olga Şoriţău Breakdown of academic impact, for papers by Simmyung Yook Breakdown of academic impact, for papers by Haiyan Sun
Rankless by CCL
2026